On Invalid Date, Palisade Bio (NASDAQ: PALI) reported Q1 2023 earnings per share (EPS) of -$0.54, up 95.83% year over year. Total Palisade Bio earnings for the quarter were -$2.34 million. In the same quarter last year, Palisade Bio's earnings per share (EPS) was -$12.96.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.